Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Doox Medica to distribute Cappella Sideguard Stent in Middle East

Doox Medica has signed an agreement to distribute Cappella's Sideguard Coronary Stent system in the Middle Eastern territories.

The Sideguard incorporates the company’s proprietary stent design and balloon delivery system and its sidebranch technology offers interventional cardiologists a solution that preserves the sidebranch of diseased coronary arteries by protecting the ostium while minimizing plaque shift.

With a strategy to accelerate commercialization, Cappella is also seeking market entry of its Sideguard product in India.

Cappella’s commitment to India will in the longer term extend to clinical trials of its next generation of products currently under development that will result in additional commercialization opportunities.

The company also annonced that its Sideguard Coronary Stent system has been approved by the Saudi Food and Drug Administration (FDA).